secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001213900-25-060467
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences amends bylaws to add jury waiver, 3% derivative threshold
-----------------------------------------------------------------------

- Adds jury trial waiver for 'internal entity claims' under Texas Business Organizations Code.
- Requires 3% ownership threshold for shareholders to initiate derivative proceedings.
- Technical revisions to clarify exclusive forum provision.
- Amendments effective June 27, 2025, filed as Exhibit 3.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390025060467/0001213900-25-060467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390025060467/ea0247855-8k_heart.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-060467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer